Women's Health · Full case

Cervical Screening

NHSCSPHPV primary screeningSymptomatic ≠ screening
CS
Cervical Screening · Clinical Reasoning Framework v2
GP & SCA · NHS Cervical Screening Programme · HPV primary screening · recall ages/intervals · result pathways · the non-attender · symptoms ≠ screening
HPV-primary screeningThe NHS programme now tests the sample for high-risk HPV FIRST; cytology is only examined if HPV is positive (reflex cytology). HPV-negative = return to routine recall — most women, even with minor cell changes, are reassured by a negative HPV result
Ages & intervalsInvited from 25 to 64. England: from 1 July 2025, 25–49s who test HPV-negative are recalled at 5 years (previously 3) — unless an HPV-positive result in the previous 5 years keeps them on 3-yearly recall; 50–64 every 5 years; under 25 not screened (HPV/minor changes common & usually regress; screening causes more harm than good). Check current local programme details
HPV+ / cytology pathwayHPV-positive with abnormal cytology → colposcopy. HPV-positive with normal cytology → repeat in 12 months; persistent HPV (still positive at repeats) → colposcopy. HPV-negative → routine recall. Know the result letters and what each means
Screening is for the WELLScreening is for ASYMPTOMATIC women. A smear is NOT the test for symptoms — postcoital, intermenstrual or postmenopausal bleeding, persistent discharge or a visibly abnormal cervix need clinical assessment/examination and the suspected-cancer pathway, regardless of a recent normal smear
Symptoms → examine & referNICE NG12: consider a suspected cancer pathway referral if, on examination, the appearance of the cervix is consistent with cervical cancer. Don't be falsely reassured by an in-date normal smear in a symptomatic woman — examine and refer on symptoms
HPV vaccination changes the pictureThe HPV vaccine (offered in school, all genders) markedly reduces cervical cancer and high-grade disease. Screening still applies to vaccinated women. The combination of vaccination + HPV screening is driving towards cervical cancer elimination
Address the barriers to attendanceNon-attendance is common — embarrassment, fear, pain, past trauma, cultural factors, trans/non-binary inclusion, disability and access. Explore barriers non-judgmentally; offer choice (female sample-taker, longer appointment, self-sampling where available), and never coerce
Special situationsPregnancy (usually defer routine screening), after total hysterectomy (usually ceases if cervix removed & no CIN history), immunosuppression/HIV (more frequent), previous CIN/treatment (test of cure & follow-up), and ceasing at 65 if adequately screened & negative
📋 Clinical Stem — Cervical Screening
A 34-year-old woman who has ignored three screening invitations out of fear and embarrassment, attending today about something else, who also mentions some bleeding after sex
Aisha Rahman, 34, books to discuss contraception, and her record shows she is overdue for cervical screening, having declined the last three invitations. When gently asked, she admits she finds the test embarrassing and is frightened it will hurt or "find something bad"; a previous smear years ago was uncomfortable. As the consultation develops, she also mentions she's had some bleeding after sex over the past couple of months, which she'd assumed was "normal". She has had a normal smear in the past and is otherwise well. She is unsure what HPV is and worries that a positive result means she's "done something wrong".
This stem tests two distinct things at once: (1) the SCREENING task — explaining HPV-primary cervical screening (what it tests, why intervals changed, what results mean), exploring and addressing the barriers to a fearful non-attender non-judgmentally, offering choice and support, and counselling about HPV without shame; and crucially (2) recognising that her postcoital bleeding is a SYMPTOM, not a screening matter — it requires clinical assessment with speculum examination of the cervix and, if the cervix looks abnormal, an urgent suspected-cancer (NICE NG12) referral, irrespective of any previous or current smear result. The SCA challenge is to support and encourage screening while not allowing a "normal smear" to falsely reassure away a red-flag symptom — separating screening from symptomatic assessment.
Scenario A — Fearful non-attender + a symptom (this stem) Explore barriers, explain HPV screening and results, de-shame HPV; but ALSO recognise postcoital bleeding as a symptom needing speculum examination ± NG12 referral — not a smear.
Scenario B — Explaining an HPV-positive result HPV+ with normal cytology → repeat 12 months; HPV+ with abnormal cytology → colposcopy; reassure re what HPV is, that it's common, and that positive ≠ cancer/blame.
Scenario C — Routine counselling/eligibility Ages/intervals, vaccination status, what the test involves; offering a female sample-taker, chaperone, longer appointment.
Scenario D — Special situations Pregnancy (defer routine), post-hysterectomy (usually ceases), immunosuppression/HIV (more frequent), previous CIN/test of cure, ceasing at 65.
Scenario E — Inclusion & access Trans/non-binary patients with a cervix, learning disability, previous sexual trauma, language/cultural barriers — tailored, trauma-informed, consent-led approaches; self-sampling where available.
Key variables to adapt for Asymptomatic screening vs symptomatic assessment (the key split); HPV-primary pathway & result letters; ages/intervals; barriers to attendance & how to address them; HPV de-shaming/vaccination; special situations; consent, choice, trauma-informed care; NG12 for a suspicious cervix/symptoms.
Steps:
1
Step 1
History — Screening vs Symptoms · Barriers · HPV Understanding · ICE · Psychosocial Context
▲collapse
This consultation runs on two tracks that must never be confused: the screening conversation (a fearful non-attender who needs barriers explored and HPV explained without shame) and the symptomatic alarm (postcoital bleeding, which is a clinical problem needing examination — not a smear). The single most important reasoning move is to hear the postcoital bleeding and pull it out of the "she just needs her smear" frame.
🎓 SCA framing — encourage screening, but don't let it mask a symptom
"I'd love to help you feel more comfortable about screening, and we'll come to that. But first — you mentioned some bleeding after sex. That's a symptom I always want to check properly, separately from screening, so let's make sure we look at that too."
The trap is to focus entirely on coaxing a reluctant patient into a smear and miss that her symptom needs a speculum examination and possibly an urgent referral. Screening is for the well; symptoms get assessed.
1A — Separate the tracks; explore barriers and understanding
QuestionWhy it mattersChanges what?
🟢 OPEN QUESTION"Before we talk about screening — tell me about the bleeding after sex. How often, how long, any other changes?" Hearing and prioritising the symptom is the pivotal step. Postcoital bleeding for two months is a red-flag symptom that requires clinical assessment (speculum examination of the cervix) and, if the cervix looks abnormal, an urgent suspected-cancer referral — regardless of any smear history. A smear is a screening test for well women, not the investigation for this symptom.In SCA: separating "symptomatic assessment" from "screening" is the core safety reasoning of the case. PCB → examine cervix ± NG12
Characterise the bleeding"Any bleeding between periods or after the menopause? Any discharge, pain, or change in your cervix you've noticed?"Postcoital, intermenstrual and postmenopausal bleeding, persistent discharge and a visibly abnormal cervix are the symptoms that mandate examination and the suspected-cancer pathway. Characterising them defines urgency and what to examine.Red-flag bleeding/discharge → speculum exam; abnormal cervix → urgent referral.Speculum examination
Screening status & barriers"I can see screening's been offered a few times — can you tell me what's put you off? Was a previous test difficult?"Non-attendance has reasons — embarrassment, fear of pain or of "bad news", past difficult/painful experiences, trauma, cultural factors, access. Eliciting them non-judgmentally is what allows you to address them (choice of sample-taker, longer appointment, gentleness, support) and convert reluctance into informed choice — never coercion.Named barriers → tailored support & choice; informed decision.Barriers → support, choice, consent
Understanding of HPV & screening"What do you understand about what the test looks for, and about HPV?"Aisha worries a positive HPV result means she's "done something wrong". Surfacing her understanding lets you explain HPV-primary screening (tests for the virus first; cytology only if HPV positive), that HPV is extremely common and not a marker of blame, and what the result pathways mean — reducing fear and shame.Misunderstanding/shame → education & reassurance; informed engagement.Explain HPV screening & results
Vaccination & risk context"Did you have the HPV vaccine at school? Any previous abnormal smears or treatment?"Vaccination status, prior CIN/treatment, immunosuppression/HIV and pregnancy all modify the screening pathway and interval. Previous treatment needs test-of-cure follow-up; HIV may mean more frequent screening; other immunosuppression follows NHSCSP or specialist advice.Prior CIN/immunosuppression/pregnancy → modified pathway/interval.Tailor interval/pathway
Sexual & contraceptive context"You came about contraception — what are you using, and any STI risk we should check given the bleeding?"The presenting agenda (contraception) and STI risk are relevant — chlamydia and other infections also cause postcoital bleeding, so STI testing is part of the symptomatic work-up alongside examining the cervix.STI risk → test (chlamydia/gonorrhoea) as part of PCB work-up.STI screen alongside exam
1B — Red flags
🚨

Red Flags — when it's symptoms, not screening

Red flagWhy it mattersAction
Postcoital / intermenstrual / postmenopausal bleeding, persistent dischargeSymptoms of possible cervical (or other gynaecological) cancer — a smear is NOT the test for these.Speculum examination of the cervix; STI testing; refer per NG12 if suspicious
Cervix looks abnormal/suspicious on examinationVisible lesion may be cancer even with a recent normal smear.Urgent suspected cancer pathway referral — NICE NG12 (updated April 2026)
Symptomatic woman with a recent normal smearFalse reassurance — screening can miss cancer; symptoms override a normal screen.Assess and refer on symptoms regardless of smear result
HPV-positive with abnormal cytology / persistent HPVRisk of high-grade CIN/cancer.Colposcopy referral per programme pathway
Repeated inadequate samples / failure to follow up abnormal resultsMissed disease through process failure.Ensure recall/colposcopy completed; fail-safe follow-up
Previous CIN/treatment or immunosuppression/HIVHigher risk; needs modified/more frequent surveillance.Follow test-of-cure / enhanced surveillance pathway
1C — ICE
💭 Ideas
"What do you think the test is for, and what's worried you about it?"
Aisha fears pain and "finding something bad", and thinks a positive HPV result implies blame. Surfacing this lets you correct misconceptions (HPV is common, not shameful; the test is quick and you can stop at any point) and demystify the process — which is what actually changes attendance.
😟 Concerns
"Is it the discomfort, the embarrassment, or the fear of the result that worries you most?"
Naming the specific barrier lets you tailor support — a female sample-taker, a smaller speculum, a longer appointment, going at her pace, stopping if she wishes. It also opens the door to any past trauma that needs a trauma-informed approach.
🎯 Expectations
"What would help you feel able to do this — today or another time?"
She controls the decision. Naming her expectations lets you offer genuine choice (now, a booked longer appointment, with a chaperone), respect her autonomy, and — separately — explain why the bleeding needs examining regardless, so she leaves clear on both.
1D — Psychosocial context
🤝 Fear, shame, autonomy — and the symptom hiding behind the screening conversation

Cervical screening sits at the intersection of fear, embarrassment, bodily autonomy and sometimes trauma — which is why invitations get declined and why a supportive, unhurried, consent-led, trauma-informed approach matters more than persuasion. But this case carries a second lesson: a reluctant-screener consultation can quietly contain a red-flag symptom. The skill is to do both well — to support and empower her around screening without any coercion, AND to lift her postcoital bleeding out of the screening frame and assess it properly, because a smear will never be the right answer to a symptom.

🙇 De-shaming HPV

Explain HPV is common and not about blame.

"HPV is incredibly common — most people who've ever been sexually active get it at some point, and it usually clears on its own. A positive result doesn't mean you've done anything wrong; it just tells us to keep a closer eye."
🤲 Choice & control

Offer options and emphasise she's in control.

"You're in charge here — we can use a smaller speculum, have a female nurse, take it slowly, and you can ask me to stop at any moment. We can also book a longer appointment if today doesn't feel right."
🧭 Separating symptom from screening

Be explicit that the bleeding is assessed regardless.

"Whatever you decide about screening, the bleeding after sex is something I'd want to look at properly — that's a check for a symptom, which is different from screening, and it's important we don't put it off."
🛡️ Trauma-informed care

Be alert to past trauma; never coerce.

"If there's ever been a difficult or painful experience that makes this hard, you don't have to tell me the details — but we can absolutely adapt how we do things so you feel safe and in control."
1E — Psychosocial context: who is under-screened, and why
🤝
Non-attendance is rarely indifference: it is usually fear, pain, shame, trauma, access or not having been told the right thing
Around a third of people eligible for cervical screening in England are not up to date (NHS England, August 2026). The people who have never been screened or are furthest overdue carry a disproportionate share of cervical cancer risk, so the fearful non-attender in front of you is exactly the person the programme most needs to reach. Ask about barriers in the history, not only in the plan: the barrier determines the support you offer, and the right support is what converts an invitation into an informed decision. Each card below is a common barrier with a question that opens it up.
😣
Fear of pain and a previous bad experience

A painful or rushed previous test is one of the commonest reasons people stop attending. Pain is often avoidable: a smaller speculum, more lubricant, a different position (left lateral, or hands under the buttocks to tilt the pelvis), inserting the speculum herself, and a sample-taker who explains and pauses on request. After the menopause, vaginal atrophy makes the test uncomfortable, and a short course of vaginal oestrogen beforehand can help (check local guidance on timing before sampling).

"You mentioned the last one was uncomfortable — can you tell me what happened? There's quite a lot we can change so it's not like that again."
🛡️
Past sexual trauma

A speculum examination can re-trigger memories of sexual violence, and people often do not disclose this. A trauma-informed approach does not need the details. It needs control handed back: agreeing a stop signal, letting her decide who is in the room, going at her pace, and offering a longer appointment or a pre-visit to meet the nurse first. Where trauma is disclosed, consider safeguarding, whether support services are wanted, and whether the abuse is ongoing.

"Some people find this test hard because of things that have happened in the past. You don't need to tell me anything, but if that's part of it, we can do things very differently so you're in charge."
🕌
Culture, faith, language and modesty

Modesty norms, family expectations, the assumption that screening is only for people with many partners, and stigma around anything sexual can all stop people coming forward. Offer a female sample-taker as standard, a professional interpreter (never a family member for an intimate consultation), and translated or easy-read resources. Frame screening as routine health care for everyone with a cervix, not a judgement on sexual behaviour.

"Everyone with a cervix is invited, whatever their relationship history — it's a routine check, like a blood pressure check, not a judgement about anyone's private life."
🏳️‍⚧️
Trans men and non-binary people with a cervix

People registered with the GP as male are not invited automatically, but anyone aged 25–64 with a cervix who has ever had sex can opt in to routine invitations through the practice (NHS Cervical Screening Programme opt-in guidance for transgender and non-binary people). Testosterone can cause vaginal atrophy, making the test more uncomfortable and cytology harder to read. Dysphoria is a real barrier. Use their chosen name and pronouns, offer the first or last appointment of the day, and make sure the lab request carries the right information. Trans women who have had vaginoplasty have no cervix and do not need screening.

"Because you're registered as male you won't get automatic letters, but you can still have screening. Would you like me to set up invitations for you, and talk about what would make the appointment easier?"
🧩
Learning disability, autism and physical disability

People with a learning disability are screened far less often than the general population, sometimes because others assume it isn't needed. The Equality Act 2010 requires reasonable adjustments: easy-read information, a pre-visit to see the room and the equipment, longer or first appointments, a familiar supporter present, and flexibility on position. Capacity to consent is decision-specific. Do not assume someone lacks it. If they do lack capacity, a best-interests decision under the Mental Capacity Act 2005 involves family, carers and the learning disability team, and taking into account whether the person has ever been sexually active. Wheelchair users need an accessible room and a height-adjustable couch, and may need a hoist.

"Would it help to come in first just to see the room and meet the nurse, without having the test that day?"
⏰
Time, work, childcare and access

Practical barriers are underestimated. Appointments that clash with shifts, no childcare, and not knowing that sexual health clinics can also take samples all add up. Offer early, late or weekend slots, and tell her about the HPV self-sampling kit. From August 2026 NHS England is rolling out, in phases, invitations to order a free home kit, starting with people aged 30–65 who are at least six months overdue. For someone who dreads a speculum, a self-sample may be the difference between no screening and some screening.

"If coming in for the test is the hard part, there's now a kit you can do at home — a simple swab you post back. It won't replace everything, but it's a very good first step."
💔
HPV, relationships and fear of blame

Aisha worries that a positive HPV result means she has "done something wrong". Many people fear it means their partner was unfaithful. HPV can lie dormant for years or decades. It cannot be dated to a particular partner, and most sexually active people have it at some point. Getting this message across before the test reduces the anxiety that stops people attending, and reduces the distress if the result is positive.

"HPV can stay quietly in the body for many years, so a positive result can't tell us when or from whom you got it. It isn't a sign that anyone has been unfaithful."
😰
Fear of cancer ("I'd rather not know")

Some people avoid screening because they fear a cancer diagnosis. Reframe it. Screening mostly finds changes before cancer develops, when treatment is simple and usually done in an outpatient clinic. For Aisha, this fear also explains why she half-ignored her bleeding. Name it gently, because it may make her more likely to put off being examined.

"Screening is really about finding changes long before they could ever become cancer. That's when they're easiest to treat — usually a quick clinic procedure."
🎓 SCA Checkpoint — Step 1TasksRelating to OthersGlobal Skills
Key phrases that score
"The bleeding after sex is a symptom — that needs examining, separately from screening." — the key safety split.
"HPV is very common and not about blame — a positive result just means we watch more closely." — de-shames.
"You're in control — female nurse, smaller speculum, stop any time." — addresses barriers with choice.
Deductions
  • Treating the postcoital bleeding as a reason for a smear, or being reassured by a previous normal smear
  • Coercing a reluctant patient instead of supporting informed choice
  • Not exploring barriers; shaming/judgmental about HPV or non-attendance
  • Not offering examination + STI testing for the symptom
🔴 Red
Misses/ignores the PCB; offers a smear as the answer to the symptom; coerces; shames HPV; no exam/referral plan
🟠 Amber
Explores screening barriers; explains HPV; notes the bleeding but is slow to separate it / arrange examination; ICE partial
🟢 Green
Separates symptom from screening; arranges speculum exam + STI test ± NG12 for PCB; explores barriers; explains HPV screening & de-shames; offers choice/consent; ICE all three
2
Step 2
Triage — Symptomatic Pathway · Result Pathways · Routine Screening
▲collapse
Triage here means routing correctly: symptoms (bleeding, suspicious cervix) onto the clinical/suspected-cancer pathway; abnormal screening results onto the colposcopy/repeat pathway; and asymptomatic eligible women onto routine screening with support.
🟣 Symptomatic

Clinical pathway

Assess / NG12
  • PCB / IMB / PMB / persistent dischargeSpeculum exam + STI test; refer per NG12 if suspicious
  • Suspicious-looking cervixUrgent suspected cancer pathway referral (NG12) — don't wait for a smear
  • Symptoms + recent normal smearAssess/refer on symptoms anyway
🟠 Result pathways

Programme follow-up

Per result
  • HPV+ & abnormal cytologyColposcopy
  • HPV+ & normal cytologyRepeat at 12 months; if still HPV+/cytology-negative, repeat again at 24 months; HPV+ at 24 months (any cytology) → colposcopy
  • Inadequate sampleRepeat no sooner than 3 months; two consecutive inadequate samples → colposcopy
🟢 Routine

Screening

Asymptomatic
  • Eligible & due (25–64)Offer screening with support/choice
  • HPV-negativeRoutine recall
  • Special situationsPregnancy/hysterectomy/immunosuppression — tailored
🎓 SCA Checkpoint — Step 2Tasks
Triage rationale
"Two separate things: the bleeding goes down a 'check a symptom' route — examination today and, if needed, a fast referral; and separately, when you're ready, we'll arrange screening with all the support to make it easier."
Deductions
  • Routing a symptom into the screening programme
  • Not knowing the HPV result pathways
3
Step 3
Examination — Speculum & Cervix (for the Symptom) · Consent · Technique
▲collapse
Because Aisha has a symptom, examination is indicated: a speculum examination to visualise the cervix (looking for a lesion/contact bleeding), bimanual as appropriate, all with consent, a chaperone and a gentle, trauma-informed technique. This is symptomatic assessment — distinct from taking a screening sample.
🔎 What to assess
CheckWhy
Speculum — visualise the cervixLook for a visible lesion, contact bleeding, abnormal appearance → NG12 referral.
STI swabsChlamydia/gonorrhoea (NAAT) — common cause of postcoital bleeding.
Bimanual (as indicated)Masses, tenderness, cervical excitation.
GeneralPallor (anaemia from bleeding); abdominal exam.
🤲 How to do it well
ElementDetail
Consent & chaperoneExplicit consent; offer/record a chaperone; female sample-taker if preferred.
Comfort & controlSmaller speculum, lubrication, explain each step, stop on request.
Trauma-informedPace, privacy, dignity; never coerce.
Don't conflateThis exam is for the symptom; a screening sample is a separate decision.
🎓 SCA Checkpoint — Step 3TasksGlobal Skills
Narration that scores
"With your consent and a chaperone, I'd like to examine your cervix to look for a cause of the bleeding, and take some swabs for infection — I'll explain each step and you can stop me any time."
Deductions
  • Not examining the cervix in postcoital bleeding
  • Omitting consent/chaperone or a trauma-informed approach
4
Step 4
Investigations — STI Tests · The Screening Sample · Understanding Results
▲collapse
For the symptom: STI testing and examination (with referral driven by the cervix appearance, not a smear). For screening: the HPV-primary sample with an understanding of how the result pathways work.
🧪 For the symptom
TestWhy
Chlamydia/gonorrhoea NAATCommon cause of postcoital bleeding.
Examination findingsA suspicious cervix → NG12 referral (not a smear).
FBC if heavy/prolonged bleedingAnaemia.
Pregnancy test if relevantExclude pregnancy-related bleeding.
📋 Screening & results
ElementDetail
HPV-primary sampleTested for high-risk HPV first; cytology only if HPV positive.
HPV-negativeRoutine recall — reassuring.
HPV+ / normal cytologyRepeat at 12 months; still HPV+ and cytology-negative → repeat again at 24 months; HPV+ at 24 months → colposcopy. Abnormal cytology at any repeat → colposcopy.
HPV+ / abnormal cytologyColposcopy.
InadequateRepeat no sooner than 3 months; two consecutive inadequate → colposcopy.
💬 "Can't a smear just check the bleeding?"

"It's a really common assumption, but no — a smear is a screening test for women who are well, to catch changes early before any symptoms. Once you have a symptom like bleeding after sex, we don't rely on a smear; we examine the cervix directly and, if there's anything that needs a closer look, we refer you quickly. So the bleeding and the screening are two separate things, and I want to deal with the bleeding properly."

🎓 SCA Checkpoint — Step 4Tasks
Key reasoning
"I'll swab for infection and examine your cervix today for the bleeding; the screening sample is a separate test I'd offer when you feel ready — and I'll explain exactly what each result would mean."
Deductions
  • Using a smear as the investigation for a symptom
  • Not understanding/explaining the HPV result pathways
5
Step 5
Formulation — Two Parallel Issues, Correctly Separated
▲collapse
The "diagnosis" here is a correct formulation that keeps the two issues apart: a symptomatic problem to assess, and a screening decision to support.
IssueFormulation & action
Symptom: postcoital bleedingNeeds speculum examination of the cervix + STI testing now; if the cervix is suspicious → urgent NG12 referral; if exam normal & STI negative but PCB persists → gynaecology/colposcopy per local pathway. Not answered by a smear.
Screening: overdue, fearful non-attenderExplore barriers; explain HPV-primary screening & de-shame HPV; offer choice/support/consent; arrange when ready — never coerce.
Don't conflate themA normal smear does not exclude cancer in a symptomatic woman; a symptom is not a reason to do a screening test.
STI as a causeChlamydia is a common, treatable cause of PCB — test and treat alongside excluding serious causes.

🚩 The whole case in one sentence

Support and empower a frightened woman around HPV-primary cervical screening — AND, completely separately, assess her postcoital bleeding as a symptom (examine the cervix, test for STIs, refer urgently if the cervix looks abnormal), never letting a previous or future smear falsely reassure away a red-flag symptom.

🎓 SCA Checkpoint — Step 5Tasks
Explaining it plainly
"There are two things going on: the bleeding, which I want to check today with an examination, and screening, which we'll sort out when you feel ready. Keeping them separate makes sure neither gets missed."
Deductions
  • Conflating screening and symptomatic assessment
  • False reassurance from smear history
6
Step 6
Referral — Suspected Cancer Pathway (Suspicious Cervix) · Colposcopy · Gynaecology · GUM
▲collapse
Referral is driven by the symptom and the screening result: a suspicious cervix goes urgently on the suspected-cancer pathway; abnormal/persistent HPV goes to colposcopy; persistent unexplained PCB goes to gynaecology; and STIs to treatment/GUM.
ReferralWho / whenUrgency
🟣 Suspected cancerCervix looks suspicious on examination (NICE NG12).Suspected cancer pathway referral · NG12
ColposcopyHPV+ with abnormal cytology; persistent HPV; per programme pathway.Per programme
Gynaecology / colposcopyPersistent unexplained postcoital bleeding with normal exam/negative STIs (local pathway; not an NG12 criterion).Urgent (local pathway)
GUM / treat STIPositive chlamydia/gonorrhoea — treat + partner notification.Soon
Programme / fail-safeEnsure recall, result follow-up, special-situation pathways.Routine
🎓 SCA Checkpoint — Step 6Tasks
Threshold
"If your cervix looks at all abnormal when I examine it, I'll refer you urgently to a specialist on the fast-track suspected cancer pathway — that's standard for any symptom like this, and most of the time it's reassuring."
Deductions
  • Not referring a suspicious cervix urgently (NG12)
  • Relying on a smear instead of referral
7
Step 7
Management — Expectation · Goals · Access & Prevention · Programme Pathway · Result Cards · Psychosocial · Follow-Up · Fail-Safe · Safety-Netting
▲collapse
Management delivers both tracks: examine and act on the symptom (treat STI, refer if suspicious, follow up persistent PCB), and support an informed, unpressured screening decision with education and choice — plus a clear safety-net.
Overview — the two tracks at a glance
⚕️ The symptom
ElementDetail
Examine the cervixSpeculum ± bimanual; STI swabs.
Act on findingsSuspicious cervix → urgent NG12; positive STI → treat + partner notification; persistent PCB → gynaecology.
Safety-netReturn if bleeding persists/worsens, new symptoms; ensure referral/result follow-up.
📋 The screening
ElementDetail
EducateHPV-primary screening, intervals, what results mean; de-shame HPV; vaccination context.
Offer choice & supportFemale sample-taker, smaller speculum, longer appointment, chaperone; self-sampling where available; book when ready.
Respect autonomyInformed choice; document; never coerce; leave the door open.
Special situationsPregnancy/hysterectomy/immunosuppression/prior CIN — tailor.
7A — Address the patient's expectation first: validate → explain → negotiate
🤝
Aisha's expectation: "just do the smear today and that'll check the bleeding too". Acknowledge it, explain why the two are different, then agree a plan
1
Validate: name the expectation and the courage behind it

For someone who has put screening off three times, offering to "get it all done at once" is a big step, and it deserves to be recognised. Her request also makes sense: she thinks a smear is a general check of the cervix. If you say "no" without acknowledging this, you risk losing her to both the examination and the screening.

"I really appreciate you being willing to be examined today — I know it's the thing you've been dreading, and that's a big step. It makes complete sense to want to get everything done in one go."
2
Explain: a screening test cannot answer a symptom

Screening is designed for people without symptoms. It tests for high-risk HPV, not for cancer. A negative HPV result would not explain her bleeding, and it could reassure both of you when it shouldn't. With a symptom, the test is to look at the cervix directly, take swabs for infection, and refer if anything looks abnormal. If the cervix is healthy, the screening sample can be taken at the same visit once she is ready, but it is a separate decision with a separate purpose.

"The screening test looks for a virus, to find people who might develop changes in the future. It isn't designed to explain bleeding, and a normal result could give us false comfort. So for the bleeding, I want to look at your cervix myself and take some swabs — that's the right test."
3
Negotiate: offer both, at her pace, in her control

Agree what happens today: an examination with a chaperone and STI swabs, with her in control. Then give her a real choice about screening. If the cervix looks healthy, the sample can be taken at the same examination if she wants, and she is due, so she doesn't need another speculum. Or she can book a longer appointment with a female nurse. If she can't face a speculum for screening, the home self-sampling kit is an option. Whatever she chooses for screening, the bleeding is still examined, and a suspicious cervix is referred urgently.

"Here's what I'd suggest: I examine you today for the bleeding, with a chaperone, and you can stop me at any point. If your cervix looks healthy and you'd like to, we can take your screening sample at the same time so you don't need to come back — but that's entirely your choice."
Key principle: the NHS Cervical Screening Programme's guidance for sample takers is clear that a screening sample is not a diagnostic test for symptoms. A symptomatic person needs a clinical examination and referral based on the symptoms and what you see. It is reasonable to take a routine screening sample at the same visit when the person is due, the cervix looks normal and they consent, but you must still act on the symptom whatever the screening result is. Never let "the smear was fine" close a symptom pathway.
7B — Why screening and assessment matter: goals tailored to Aisha
Goals of this consultation and the weeks after
Cervix examined today (speculum, chaperone, consent)Suspicious cervix → suspected cancer pathway referral (NG12: "consider"; NHSCSP sample-taker guidance: refer), sent the same day Chlamydia/gonorrhoea NAAT; treat and arrange partner notification if positivePersistent unexplained PCB with a normal-looking cervix → gynaecology/colposcopy per local pathway Informed screening decision: HPV explained without blame; barriers addressedScreening completed: clinician sample (at exam or booked) or home self-sample Contraception sorted (her original agenda)Written safety-net; result and referral fail-safe in place
Motivational language, tailored to Aisha
"Most people who test positive for HPV never develop anything serious — the body clears it. Screening just means that if it doesn't clear, we catch any changes years before they could cause a problem, when treatment is simple."
"You've told me the fear of 'finding something bad' is what's kept you away. Honestly, the best way to make sure nothing bad happens is to look — and we can make the looking as comfortable as possible."
25–64
Eligible screening ages, NHS Cervical Screening Programme (England)
5 years
Recall for HPV-negative 25–49s screened from 1 July 2025 (NHS England, June 2025); 3 years if HPV+ in the previous 5 years
12 → 24 months
HPV+/cytology-negative: repeat at 12 months, then 24 months; still HPV+ at 24 months → colposcopy (NHSCSP care pathway)
30–65, ≥6 months overdue
First phase eligible to order an HPV self-sampling kit, invited via NHS App, text, email or letter (NHS England, August 2026)
~1 in 3
Eligible people in England not up to date with screening (NHS England, 2026)
~400,000/yr
Estimated extra people screened each year by offering self-sampling (YouScreen trial, reported by CRUK 2026)
1 dose
HPV vaccine schedule for adolescents and GBMSM under 25 since 1 September 2023 (UKHSA, JCVI advice)
HIV
People living with HIV may need more frequent (historically annual) screening: check current NHSCSP guidance with the HIV clinic
12 weeks
Postnatal: routine screening due in pregnancy is deferred until 12 weeks after the birth (NHSCSP)
7C — Non-drug management: what actually gets people screened and protected
In this topic, "management" is mostly communication, access and prevention. The cards below describe the interventions that move a fearful non-attender to an informed decision, and the prevention messages that sit alongside screening. Each one gives the mechanism, how to do it in practice, and a target.
🗣️
Explain HPV without blame
Target: patient can say in her own words what the test looks for
Mechanism

Fear and shame about what a result "means" are major barriers. Explaining that high-risk HPV causes almost all cervical cancers, that most sexually active people get it, that it usually clears within a couple of years, and that it can lie dormant for years reduces stigma and anticipatory anxiety.

Practical

Use chunk-and-check. Explain the order: the sample is tested for HPV first, and cells are only looked at if HPV is found. Say plainly that a positive HPV result is not cancer, is not a sign of infidelity, and usually means "watch", not "treat". Offer the NHS leaflet in her language.

Informed choice is the programme standard, not uptake at any cost
✒️
Comfort adjustments
Target: a test she would be willing to repeat
Mechanism

A painful test causes future non-attendance. Much of the discomfort comes from speculum size, angle, a dry or atrophic vagina, and muscle guarding because of fear. Changing these, and giving back control, reduces pain.

Practical

Smaller or plastic speculum, water-based lubricant, alternative positions, self-insertion of the speculum, an agreed stop signal, a longer appointment and a female sample-taker. After the menopause or on testosterone, consider a short course of vaginal oestrogen first (follow local guidance on timing). Record what helped so next time is easier.

One good experience changes future attendance
📦
HPV self-sampling (home kit)
Target: offer to anyone eligible who won't have a speculum test
Mechanism

A vaginal swab taken by the person themselves detects high-risk HPV with accuracy comparable to a clinician-taken sample for HPV testing. It removes the speculum and the appointment. The UK National Screening Committee recommended self-sampling for under-screened people in 2025.

Practical

NHS England began a phased rollout in August 2026: people aged 30–65 who are at least six months overdue are invited (NHS App, text, email or letter) to order a free kit to their home. HPV-negative → routine recall. HPV-positive → invited for a clinician-taken sample so cytology can be done. It is a screening test only. It is never the answer for someone with symptoms, including Aisha's bleeding.

YouScreen: ~400,000 more people screened a year
💉
HPV vaccination
Target: every eligible person vaccinated before their 25th birthday
Mechanism

The vaccine prevents infection with the high-risk HPV types that cause most cervical cancers. Since 1 September 2023 the universal school programme (age 12–13, all genders) and the GBMSM programme for those under 25 use a single dose (GBMSM aged 25–45 still have 2 doses) (UKHSA, following JCVI advice). People who are immunosuppressed or living with HIV need more doses, as set out in the Green Book.

Practical

People who missed the school dose can catch up via their GP until their 25th birthday. Aged 34, Aisha is past this, so vaccination is not a routine NHS offer for her. Vaccinated people must still attend screening, because the vaccine does not cover every high-risk type and does not clear an existing infection.

Vaccination + screening = route to elimination
🚭
Smoking cessation
Target: offer a referral to stop-smoking support if she smokes
Mechanism

Smoking is an established co-factor for cervical cancer. It is associated with HPV persistence and progression to high-grade CIN, probably through reduced local immunity in the cervix. For someone who is HPV-positive, stopping smoking is one of the few things they can do themselves.

Practical

Ask very briefly and advise stopping. Refer to NHS stop-smoking services and offer pharmacotherapy or vapes as locally commissioned. Link it directly to HPV: "stopping smoking helps your body clear the virus".

Gives an HPV-positive patient something active to do
🧪
Sexual health for the symptom
Target: NAAT today; results and treatment within days
Mechanism

Chlamydia cervicitis is a common, treatable cause of postcoital bleeding, and the cervix may look inflamed and bleed on contact. Cervical ectropion (often on the combined pill) and polyps are other benign causes. None of them can be assumed without examining the cervix.

Practical

Take a vulvovaginal or endocervical NAAT for chlamydia and gonorrhoea. Offer HIV and syphilis testing according to risk. Treat positives according to BASHH guidance (dose per SPC), and arrange partner notification and a test of cure where indicated. Advise condoms with a new partner. Condoms reduce, but do not eliminate, HPV transmission.

Treating an STI does not remove the need to refer a suspicious cervix
7D — Programme pathway guide: NHS Cervical Screening Programme (England), eligibility, intervals and special situations
This topic has no prescribing ladder. Instead, the national screening pathway plays that role. England uses HPV primary screening: the sample is tested for high-risk HPV first, and cytology is done only on HPV-positive samples. Intervals and exceptions are set nationally. Invitations are sent centrally, but the practice keeps the fail-safe, handles exceptions and records informed dissent. Check the current NHSCSP guidance for detail, because the programme has changed repeatedly since 2019. Scotland, Wales and Northern Ireland run their own programmes.
GroupWhat the programme doesPractice action
Under 25Not screened. HPV infection and minor cell changes are very common at this age and usually regress, so screening would lead to overtreatment. The first invitation is sent shortly before the 25th birthday.Symptoms at any age are assessed clinically, and are never a reason to screen early.Examine symptoms; don't screen
25–49From 1 July 2025, people who test HPV-negative are recalled at 5 years (previously 3). Anyone with an HPV-positive result in the previous 5 years stays on 3-yearly recall even if the current test is negative. People last screened before July 2025 keep their existing due date.Routine recall per result letter
50–645-yearly recall.Routine recall
65 and overInvitations stop at 65 unless a recent test was abnormal or follow-up is still under way. Anyone aged 65 or over who has never been screened can ask for a test.Postmenopausal bleeding at any age is a symptom, assessed under NICE NG12 (suspected cancer pathway referral for endometrial cancer at 55 and over; consider at under 55), not through screening.Offer test if never screened
PregnantRoutine screening that falls due in pregnancy is deferred until 12 weeks after the birth. If the person is due for follow-up after an abnormal result or colposcopy, discuss with colposcopy rather than simply deferring. Bleeding in pregnancy is assessed clinically.Defer routine; don't defer follow-up
After hysterectomyTotal hysterectomy for benign disease with no CIN in the specimen: no cervix, so ceased from the programme. Subtotal hysterectomy (cervix kept): stays in the programme. CIN or cervical glandular disease in the specimen: vault sampling according to NHSCSP guidance.Check histology before ceasing
Living with HIVNHSCSP has recommended annual screening, but annual invitations are not generated by the national call/recall system, and recent guidance may apply routine intervals when HIV is well controlled. Check the current NHSCSP guidance and agree the interval with the HIV team.Check interval; liaise with HIV clinic
Other immunosuppressionExamples include transplant recipients and people on dialysis or long-term immunosuppressants. Make sure they are up to date, follow NHSCSP or specialist advice on timing, and have a low threshold for examination and referral if symptoms occur.Up to date; specialist advice
Trans men / non-binary with a cervixNot invited automatically if registered as male. They can opt in to routine invitations through the practice (NHSCSP opt-in guidance). Trans women do not need cervical screening.Offer opt-in; adapt appointment
After treatment for CINTest of cure: a sample taken in the community about 6 months after treatment. HPV-negative → recall in 3 years. HPV-positive → back to colposcopy.Ensure test of cure done
Informed decline or opt-outScreening is a choice. A person can decline an invitation or ask to be permanently ceased. Ceasing needs informed, recorded consent, and the decision can be reversed at any time. Declining screening never means declining assessment of symptoms.Document informed dissent
Step 1 — HPV test on every sample
  • Clinician-taken liquid-based sample or home self-sample
  • HPV-negative → routine recall at the age-appropriate interval. No cytology is done
  • Most results are HPV-negative, which gives strong reassurance for years ahead
An HPV-negative result is not a "normal smear" to wave at a symptom. It reflects future risk, not current symptoms.
Step 2 — HPV+: reflex cytology
  • Cytology negative → repeat at 12 months
  • At 12 months, still HPV+ and cytology-negative → repeat at 24 months
  • HPV+ at 24 months (any cytology) → colposcopy
  • HPV-negative at either repeat → back to routine recall
  • Self-sample HPV+ → clinician-taken sample needed for cytology
Waiting 12 months gives the virus time to clear, which it does in most people. This is deliberate, not neglect.
Step 3 — HPV+ with abnormal cytology: colposcopy
  • Borderline or low-grade dyskaryosis → routine colposcopy referral
  • High-grade dyskaryosis, possible invasion or glandular neoplasia → urgent colposcopy (NHSCSP colposcopy standards set shorter waits for these)
  • Two consecutive inadequate samples → colposcopy
  • Referral is made by the programme or lab. The practice checks that the appointment happens
Symptoms bypass all of this. A cervix that looks suspicious → consider a suspected cancer pathway referral (NICE NG12), whatever the screening history.
7F — Result and management pathway cards (the "drug cards" for this topic)
HPV-negative result
Clinician-taken or self-sample · no cytology performed
Routine recall5 years (25–64); 3 years if HPV+ within previous 5 years
✓ What it means
Very low risk of developing cervical cancer before the next invitation. The 5-year interval for 25–49s (from July 2025) is based on this
Cytology is not examined, so the letter will not mention "cells". Explain this in advance so it doesn't cause confusion
✗ What it does NOT mean
It does not explain or exclude a cause for symptoms. Postcoital, intermenstrual or postmenopausal bleeding, or a suspicious cervix, is still assessed and referred on clinical grounds
It is not permanent protection. New infection is possible, which is why recall continues
🔬 Practice fail-safe
Check the recall date is set correctly. Transitional rules apply to people last screened before 1 July 2025 or HPV-positive in the previous 5 years
💬 Counselling

"Your test didn't find the virus that causes almost all cervical cancers, so your risk is very low and we'll invite you again in five years. If you ever get bleeding after sex, between periods, or after the menopause, don't wait for your next screening — come and see us."

Linking the negative result to a symptom safety-net shows you understand that screening and symptoms are separate. That is the core reasoning point in this case.

HPV-positive, cytology negative
High-risk HPV found · no abnormal cells
Early repeatRepeat at 12 months → 24 months → colposcopy if still HPV+
✓ Pathway
Repeat HPV test at 12 months. HPV-negative → routine recall. HPV+ with abnormal cytology → colposcopy. HPV+ with negative cytology → repeat again at 12 months (24 months after the first test)
HPV+ at the 24-month test, whatever the cytology → colposcopy referral
✗ Pitfalls
Repeating the test early ("just to check") gives no useful information and causes anxiety. Follow the programme interval
Missing the 12-month repeat: people who don't attend are the ones at risk. Make sure the reminder happens
⚠ Psychological impact
Anxiety, relationship worries, fear of cancer. De-shame HPV: it is common, can be dormant for years, can't be dated to a partner, and most infections clear
🔬 Monitor
Recall set at 12 months. Offer stop-smoking support if she smokes. She should still come back sooner with any symptoms
💬 Counselling

"The test found HPV but no abnormal cells. That's very common and usually means your body just hasn't cleared the virus yet — most people clear it within a year or two. We'll recheck in 12 months. It isn't cancer, and it doesn't tell us anything about you or your partner's faithfulness."

Scenario B: the marks come from explaining the 12-month repeat as "giving the body time to clear it" and from explicitly removing blame. Getting the 12 → 24 month → colposcopy sequence right is the Tasks mark.

HPV-positive with abnormal cytology
Borderline / low-grade / high-grade dyskaryosis · glandular · possible invasion
ColposcopyReferral via programme; urgency by cytology grade
✓ Pathway
Colposcopy referral is triggered by the result. High-grade, glandular or possible-invasion results are seen more quickly, according to NHSCSP colposcopy standards
At colposcopy: examination with acetic acid ± iodine, and biopsy if needed. High-grade CIN is usually treated by large loop excision of the transformation zone (LLETZ), often at the same visit. Low-grade CIN is often monitored
✗ Pitfalls
Not checking that colposcopy was attended. People who don't attend need active follow-up (practice fail-safe)
Using "abnormal cells" and "cancer" as if they mean the same thing. They don't. Most abnormal cytology is pre-cancerous change
⚠ After treatment
LLETZ is associated with a small increase in the risk of preterm birth in later pregnancies. Ask about previous treatment when booking antenatal care. Test of cure about 6 months after treatment
🔬 Monitor
Colposcopy attendance. Test-of-cure sample done and result actioned (HPV-negative → 3-year recall; HPV-positive → colposcopy)
💬 Counselling

"Some of the cells show changes — this isn't cancer, it's the kind of change screening is designed to find early. The next step is a closer look called colposcopy. If treatment is needed, it's usually a short procedure under local anaesthetic, often done at the same visit."

Separating "abnormal cells" from "cancer", and explaining what happens at colposcopy, reduces the fear that leads to missed appointments.

Inadequate sample
Lab unable to give a result
RepeatNot before 3 months; 2 consecutive → colposcopy
✓ Pathway
Repeat the sample after at least 3 months. After two consecutive inadequate samples → colposcopy
Look for the reason: atrophy, heavy blood or discharge, a cervix that couldn't be seen, or a sampling or labelling error. Fix it before repeating
✗ Pitfalls
A cervix that couldn't be seen properly in a symptomatic woman is an examination problem, not a screening problem. Arrange assessment or referral
🔬 Monitor
Sample-taker audit of inadequate rates, as part of NHSCSP sample-taker good practice
💬 Counselling

"The lab couldn't get a result from the sample — it's nothing you did, and it isn't a sign of anything wrong. We need to repeat it after a few months, and we'll make sure it's as comfortable as possible."

Apologise, explain and fix the cause. An inadequate result after a hard-won first attendance can put a fearful patient off for years.

Symptomatic pathway: postcoital / intermenstrual / postmenopausal bleeding
Clinical assessment · not a screening test
Examine ± NG12Speculum today; suspicious cervix → suspected cancer pathway referral
✓ Pathway
Speculum examination of the cervix with a chaperone and consent. STI NAAT. Pregnancy test if relevant
Appearance consistent with cervical cancer → consider a suspected cancer pathway referral (NICE NG12)
Normal-looking cervix, negative STIs, but postcoital bleeding persists → refer to gynaecology/colposcopy according to the local pathway
Postmenopausal bleeding follows the NG12 endometrial pathway, which is separate from cervical screening
✗ Never
Never offer a screening sample (clinician or self-sample) as the investigation for a symptom
Never be reassured by a recent normal screening result in a symptomatic person
🔬 Monitor
Follow up STI results. Track referrals. Review if bleeding continues after a benign cause has been treated
💬 Counselling

"Bleeding after sex is usually caused by something harmless, like an infection or a sensitive area on the cervix. But it's a symptom I always check properly, by looking at the cervix, rather than relying on a screening test."

This is the card the case turns on. Candidates who swab, examine and give a clear referral threshold pass. Candidates who "do a smear to check the bleeding" fail the Tasks domain.

HPV self-sample result
Home kit, ordered after an invitation; first phase is people aged 30–65 who are ≥6 months overdue (NHS England, 2026)
Screening onlyHPV+ → clinician-taken sample for cytology
✓ Pathway
HPV-negative → routine recall. HPV-positive → invited for a clinician-taken sample (GP or sexual health clinic) so cytology can be done, then the standard pathway. Unusable sample → offered a repeat or a clinician-taken sample
✗ Not for
Anyone with symptoms. They need examination
Cannot assess cytology. An HPV-positive self-sample must be followed by a clinician-taken sample
🔬 Practice role
Make it easy to book the follow-up sample after an HPV-positive self-sample, with adjustments already recorded (female sample-taker, longer slot)
💬 Counselling

"The home kit found HPV, so the next step is a sample from the cervix so the lab can look at the cells. We'll book a longer appointment with a female nurse, and we can use everything that helps make it comfortable."

Offering self-sampling to a reluctant, asymptomatic patient scores in Relating to Others. Offering it to Aisha as a substitute for examining her bleeding loses the Tasks marks.

7G — Psychosocial impact of results and referral: relationships, work, fertility and identity
🤝
A letter, a referral or an examination can reach far beyond the cervix: into trust, sex, work and plans for a family
The wait between "HPV found" or "I'm referring you urgently" and the answer is when anxiety peaks. Aisha is in a new-ish relationship, came about contraception, and has avoided screening out of fear. Whatever the examination shows, how the news is framed will shape whether she keeps engaging, both with this pathway and with screening for the next 30 years.
💑
Relationships and disclosure

An HPV-positive result or an STI diagnosis can put strain on a relationship. HPV does not need partner notification and cannot be dated to a partner. Chlamydia does need partner notification, which sexual health services can do anonymously. Separate the two clearly so she doesn't mix up their implications.

"HPV isn't something partners need to be told about or tested for. If the swab shows chlamydia, that's different — both of you would need treatment, and the clinic can let partners know without using your name."
⏳
The wait after an urgent referral

"Suspected cancer referral" sounds terrifying. Explain that it is a fast-track route to a specialist, that most people referred don't have cancer, and exactly when she should expect contact. Check her contact details and make sure she knows who to call if she hears nothing.

"This referral means you'll be seen quickly by a specialist. Most people seen this way don't have cancer, but we don't take chances with symptoms. If you haven't heard within a week, call us and we'll chase it."
👶
Fertility and future pregnancy

People worry that colposcopy or treatment will affect fertility. LLETZ does not usually affect the ability to conceive, but it is associated with a small increase in the risk of preterm birth. That is why previous treatment is recorded at antenatal booking. Aisha is sorting contraception now. Choosing a method is not affected by screening, but she can raise this if she has plans for pregnancy.

"If you ever need treatment on the cervix, it doesn't usually stop you getting pregnant. We'd just let your midwife know, so they can keep a closer eye in a future pregnancy."
💼
Work and practical life

Colposcopy, repeat tests and a possible urgent referral mean time off work. Cancer-screening appointments are generally accommodated, but some people feel unable to ask. Offer appointment times that fit, and a fit note only if a procedure genuinely needs recovery time (most people return to normal activity quickly after LLETZ).

"Would it help if we booked this at a time that fits around your work? Most people go back to normal activities the same or the next day."
👤
Body image, sex and identity

After bleeding with sex, and while waiting for results, many people avoid sex out of fear of causing harm or passing something on. Give specific advice: after LLETZ, avoid penetrative sex for the period the clinic advises. For trans and non-binary patients, a gynaecology pathway can deepen dysphoria. Correct names and pronouns on referrals, and forewarning the service, make a real difference.

"It's completely understandable if the bleeding has made you anxious about sex. Until we know what's causing it, using condoms is sensible, and we'll give you clear advice once we have the results."
🔁
Future screening engagement

How this episode is handled predicts whether she comes back in 3 or 5 years. Record what helped in her notes: female sample-taker, small speculum, extra time, trauma-informed approach. Then the next invitation starts from a better place, and the fearful non-attender becomes a regular attender.

"I'll make a note of what helped today — the smaller speculum, having extra time — so whoever sees you next time knows exactly how to make it easier."
7H — Follow-up schedule
1
Today: examine, swab and decide

Speculum examination with a chaperone and consent. NAAT for chlamydia and gonorrhoea. Pregnancy test if relevant. If the cervix looks suspicious → suspected cancer pathway referral sent today, and the patient told why. If the cervix looks healthy and she is due and consents → screening sample can be taken at the same examination. If not → book a longer screening appointment with a female sample-taker, or tell her about self-sampling. Sort out the contraception she came for. Safety-net given in writing.

NG12 referral if suspiciousContraception addressed
2
Within 1–2 weeks: STI results and referral check

Positive STI → treat according to BASHH guidance (dose per SPC), arrange partner notification and advise abstaining until treatment is complete. If referred urgently, confirm the appointment has been made and she knows the date. Negative STIs and a normal-looking cervix: plan a review if the bleeding continues.

Treat + partner notificationReferral fail-safe
3
4–6 weeks: is the bleeding resolved?

If postcoital bleeding persists despite treating any infection, with a normal-looking cervix → gynaecology or colposcopy referral according to the local pathway. If the bleeding resolved after STI treatment, document and reinforce the safety-net. If screening hasn't happened, offer it again without pressure.

Persistent PCB → gynaecology
4
Screening result letter: act on the result

The result letter goes to the patient and the practice. HPV-negative → recall set. HPV+/cytology-negative → 12-month recall. HPV+/abnormal cytology → colposcopy referral made by the programme, and the practice checks she attends. Offer a phone call to explain any result that is not negative.

Explain non-negative results
5
12 months (if HPV+): repeat test

Repeat HPV test. Still HPV+ with negative cytology → repeat at 24 months. Still HPV+ at 24 months → colposcopy. Any abnormal cytology → colposcopy. HPV-negative → routine recall. If she has had treatment: test of cure about 6 months afterwards.

12 → 24 months → colposcopy
7I — Monitoring: the practice fail-safe

Memory rule: "Symptom tracked, Result actioned, Referral attended, Recall correct" (STRR)

For every patient: symptom (resolved, or referred?); result (letter received, understood, next step set?); referral (suspected cancer or colposcopy appointment attended?); recall (right interval under the July 2025 rules, and exceptions such as HIV, hysterectomy, pregnancy or trans opt-in correctly coded?).

WhatHowWhenAction threshold
Suspected cancer referralReferral tracker; confirm appointmentWithin days of referralNo appointment or did not attend → contact the patient and re-refer or chase
STI resultsLab result review1–2 weeksPositive → treat, partner notification, test of cure if indicated
Persistent PCBPlanned review4–6 weeksOngoing bleeding with a normal-looking cervix → gynaecology/colposcopy per local pathway
Colposcopy attendanceHospital notification / non-attendance reportsAfter each referralDid not attend → contact the patient, explore barriers, rebook
Prior notification listPractice reviews the list of people due to be invitedBefore invitations go outFlag exceptions (e.g. total hysterectomy with no cervix). Never suspend someone just because they previously didn't attend
Special groupsCoded registersAnnual checkHIV → interval agreed with HIV clinic per current NHSCSP guidance; trans/non-binary opt-in recorded; pregnancy deferral re-activated postnatally
Sample-taker qualityInadequate-rate audit; training updatesRegularly, per NHSCSP guidanceHigh inadequate rate → review technique and training
7J — Safety-netting: exact phrases, RAG marking and danger zones

⚠ Three scenario-specific phrases: use these word for word

🔴 Symptom: bleeding continues, or new symptoms
"If the bleeding after sex carries on, or you get bleeding between periods, heavier or smelly discharge, pain during sex, or pelvic pain, please come back — don't wait for a screening letter. Even if a screening test comes back normal, those symptoms still need checking."
This separates the screening result from symptoms explicitly. Delayed diagnosis of cervical cancer often involves symptomatic women who were reassured by a normal screening result.
📬 Referral / result fail-safe
"You should hear about the specialist appointment within the next few days. If you haven't heard in a week, or anything doesn't make sense, call us and we'll chase it. The same goes for your swab results — we'll contact you if you need treatment, but please call if you haven't heard in two weeks."
Sharing responsibility for the fail-safe with the patient reduces the chance of a lost referral, which is a common cause of harm and complaints.
🟠 Screening: leave the door open
"There's no pressure on the screening. Whenever you feel ready, call and ask for a longer appointment with a female nurse, and we'll use the smaller speculum. And if you're invited to order a home testing kit, that's a good option too — it's only for screening, not for the bleeding."
This keeps informed choice intact and makes re-engagement easy. It also restates that self-sampling is not a symptom test.
1–2 weeksSTI results actioned; referral appointment confirmed
4–6 weeksPCB resolved? Persistent → gynaecology/colposcopy
Result letterExplain non-negative results; 12-month recall or colposcopy
🔴🟠🟢 RAG: all 3 domains
Tasks
🟢
PCB recognised as a symptom; speculum + NAAT; NG12 threshold stated; screening explained accurately (HPV first, reflex cytology, 12 → 24 months, intervals); self-sampling offered correctly; contraception addressed
🟠
Examines, but the referral threshold is vague; result pathway partly right; no STI test or no persistent-PCB plan
🔴
Smear or self-sample offered "to check the bleeding"; reassured by a past normal smear; no examination
Relating to Others
🟢
Barriers explored with curiosity; HPV de-shamed; control handed back; her "do it all at once" request validated before being redirected
🟠
Kind but directive; barriers noted but not addressed; HPV explained in jargon
🔴
Coercive or judgemental about non-attendance; HPV framed as blame; no consent or chaperone
Global Skills
🟢
Two tracks signposted and kept separate; time managed so contraception isn't dropped; written safety-net
🟠
Tracks merge in places; safety-net verbal only
🔴
Runs out of time on screening persuasion; symptom or safety-net missed
💬 Key phrases
💭 Ideas: what she thinks the test is
"What do you understand the screening test is looking for?"
😟 Concerns: name the barrier
"Is it the discomfort, the embarrassment, or what it might find that worries you most?"
🎯 Expectation redirected
"The screening test looks for a virus; it can't explain bleeding. For the bleeding, I want to look at your cervix myself."
🤲 Control handed back
"You're in charge — female nurse, smaller speculum, and you can say stop at any moment."
🔬 De-shame HPV
"HPV is extremely common, can stay quiet for years, and a positive result says nothing about you or your partner's faithfulness."
📋 Close
"So: we check the bleeding properly today, and screening is your choice, whenever you're ready. What questions do you have?"
🚫 Danger zones
✗
"Let's do a smear to check the bleeding"→ A screening sample is not a diagnostic test. Examine the cervix, swab, and refer if suspicious (NICE NG12).
✗
Reassured by a previous normal smear→ Screening can miss disease, and symptoms override it. Act on what you see and hear.
✗
Offering the home self-sample kit for symptoms→ Self-sampling is for asymptomatic, under-screened people only. Symptoms need examination.
✗
Out-of-date intervals→ 25–49 HPV-negative → 5 years from 1 July 2025 (3 years if HPV+ in the previous 5 years). HPV+/cytology-negative → 12 → 24 months → colposcopy.
✗
Coercion ("you really must")→ Screening is an informed choice. Explore barriers, offer adjustments, document the decision and leave the door open.
✗
Ceasing after hysterectomy without checking histology→ Subtotal hysterectomy (cervix kept) or CIN in the specimen → continue screening or vault sampling according to NHSCSP guidance.
✗
Forgetting trans men and non-binary people→ If registered as male, they are not invited automatically. Offer opt-in and adapt the appointment.
✗
Dropping her original agenda→ She came about contraception. Address it, or book it explicitly. Leaving it out loses Global Skills marks.
🎓 SCA Checkpoint — Step 7TasksRelating to OthersGlobal Skills
A plan that scores
"So: today I'll examine you and swab for infection because of the bleeding, and refer urgently if anything looks off. Separately, I've explained screening and HPV — there's no pressure; when you feel ready we'll book a longer appointment with a female nurse and all the support to make it comfortable. Come back sooner if the bleeding continues."
Deductions
  • Substituting a smear for symptomatic assessment
  • Coercing screening; shaming HPV/non-attendance
  • No safety-net / result follow-up
Cervical Screening — SCA Consultation Scorecard
Screening vs symptoms · HPV-primary & results · barriers/de-shame · NG12 for a suspicious cervix
0/ 33 pts
🌐
Global Skills
Structure, language, responsiveness
0/7
✓
Tasks
Clinical reasoning, screening, management
0/15
🤝
Relating to Others
Communication, rapport, shared decisions
0/11
RAG Self-Assessment
🔴 Red
PCB treated as a smear matter; no exam/NG12; coerces screening; shames HPV; no safety-net
🟠 Amber
Explains screening & barriers; notes the bleeding but slow to separate/examine; HPV partly explained; ICE partial
🟢 Green
Separates symptom from screening; examines cervix + STI + NG12 if suspicious; explains HPV-primary & de-shames; barriers/choice/consent; ICE all three; safety-net
011172533
Fail
Borderline
Pass
Strong pass
📋
Complete the checklist to see your score and feedback
"I actually came about my contraception… I know you'll say I'm overdue for a smear — I just really don't like them, they frighten me. (later) …I suppose I should mention I've had a bit of bleeding after sex, but that's probably nothing, isn't it?"
Who you are

Aisha Rahman, 34. You booked about contraception. You've declined the last three cervical screening invitations because you find the test embarrassing and frightening — you're scared it'll hurt (a previous one was uncomfortable) and scared it'll "find something bad". You don't really understand HPV and worry a positive result would mean you'd "done something wrong". Partway through, you mention you've had some bleeding after sex over the last couple of months, which you assumed was normal. You had a normal smear years ago. Otherwise well.

Hidden concerns (reveal if explored)

Fear/embarrassment (main): the test itself frightens you; reassurance about choice and control helps a lot.

Shame about HPV: you think a positive result means infidelity/blame — huge relief when told it's common and not about that.

The bleeding: you've half-ignored it and assumed it's nothing; you're reassured that the doctor takes it seriously but checks calmly.

Clinical details if asked
  • Postcoital bleeding for ~2 months; no intermenstrual or postmenopausal bleeding; some on-and-off discharge
  • Declined last 3 screening invites; previous smear normal years ago; had the HPV vaccine? unsure
  • New-ish relationship; possible STI risk; no contraception sorted yet (reason for visit)
  • No pain, no weight loss; otherwise well; not pregnant (will do test)
  • Willing to be examined if approached gently, with consent and a female chaperone
Reactions at key moments
  • If the doctor offers a smear "to check the bleeding": you go along with it — so a good candidate must NOT do this and should explain why.
  • On separating symptom from screening: reassured someone's taking the bleeding seriously.
  • On HPV being de-shamed: visibly relieved.
  • On choice/control for any exam: much more willing.
  • Challenge line: "Can't you just do the smear and that'll tell us about the bleeding too?"
"Can't you just do my smear today and that'll check the bleeding as well? Then it's all done at once and I don't have to come back."

Resolution: Aisha is well served if the GP: (1) recognises the postcoital bleeding as a symptom requiring speculum examination of the cervix + STI testing — explicitly NOT answered by a smear — and refers urgently (NG12) if the cervix looks suspicious, undeterred by her previous normal smear; (2) explores her barriers to screening non-judgmentally and explains HPV-primary screening, intervals and results, de-shaming HPV; (3) offers genuine choice and support (female sample-taker, smaller speculum, longer appointment, consent, control) without coercion; (4) keeps the two tracks separate and safety-nets. She is poorly served if given a smear as the "investigation" for her bleeding, falsely reassured, coerced, or shamed.

🏥
Clinic Quick Reference
Cervical Screening — Clinical Decision Framework
HPV-primary · screening vs symptoms · result pathways
▼expand
🔀 1 — Screening vs symptoms
Screening (asymptomatic)

HPV-primary (HPV first, reflex cytology). 25–64; HPV− → routine recall; HPV+ normal cytology → repeat 12m (persistent → colposcopy); HPV+ abnormal cytology → colposcopy. Address barriers; offer choice; de-shame HPV.

Symptoms — NOT a smear

PCB/IMB/PMB/persistent discharge → speculum exam of the cervix + STI test; suspicious cervix → urgent NG12. A normal smear does NOT exclude cancer in a symptomatic woman.

📋 2 — Practicalities

Offer female sample-taker, smaller speculum, longer appointment, chaperone, self-sampling where available; trauma-informed, consent-led, never coercive. Special situations: pregnancy (defer routine), post-hysterectomy (usually ceases), immunosuppression/HIV (more frequent), prior CIN (test of cure), cease at 65 if adequately screened & negative. Vaccination + screening drive elimination.

🎓
SCA Quick Reference
Cervical Screening — Consultation Playbook
Screening ≠ symptoms · de-shame HPV · choice not coercion
▼expand
🎯 The three pivots that pass this case
1 · Symptom ≠ screening
Postcoital bleeding needs a speculum exam + STI test (± NG12), NOT a smear. A normal smear doesn't exclude cancer.
2 · Explain & de-shame
HPV-primary screening (HPV first, reflex cytology); HPV is common and not blame; explain the result pathways.
3 · Choice, not coercion
Explore barriers; offer female sample-taker, smaller speculum, longer appointment, consent and control.
⛔ Don't offer a smear as the test for a symptom · Don't be falsely reassured by a normal smear in a symptomatic woman — examine & refer (NG12) · Don't coerce a reluctant patient — support informed choice · Don't shame HPV or non-attendance · Be trauma-informed and consent-led
Reviewed: July 2026 · citations verified against the primary sources listed